The Latest Breaking News from Ocular Therapeutix

Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD).

Benzinga · Dec 8, 2025

Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts

Across the recent three months, 4 analysts have shared their insights on Ocular Therapeutix (NASDAQ:OCUL), expressing a variety of opinions spanning from bullish to bearish.

Benzinga · Dec 3, 2024

3 Standout Stocks Under $10 With 86% Upside Potential or More

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

Barchart · Jul 24, 2024